(Q28585742)

GOA release 2020-03-11

1 reference

M. de Chaldée

1

1 reference

31 January 2017

C. Brochier

2

1 reference

31 January 2017

A. Van de Vel

3

1 reference

31 January 2017

N. Caudy

4

1 reference

31 January 2017

R. Luthi-Carter

5

1 reference

31 January 2017

M. C. Gaillard

6

1 reference

31 January 2017

J. M. Elalouf

The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia

7

1 reference

31 January 2017

1 February 2006

1 reference

31 January 2017

1 reference

31 January 2017

87

1 reference

31 January 2017

200–207

1 reference

31 January 2017

2

1 reference

31 January 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Cocaine receptors on dopamine transporters are related to self-administration of cocaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

A complex program of striatal gene expression induced by dopaminergic stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Isolation of clones of rat striatum-specific mRNAs by directional tag PCR subtraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Rhes is involved in striatal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

A novel G-protein-coupled receptor gene expressed in striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Quantitative assessment of transcriptome differences between brain territories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Serial analysis of gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Phactrs 1-4: A family of protein phosphatase 1 and actin regulatory proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

A novel Golgi membrane protein is a partner of the ARF exchange factors Gea1p and Gea2p.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Distribution and cellular localization of DARPP-32 mRNA in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Transmitter histochemistry of the rat olfactory bulb. I. Immunohistochemical localization of monoamine synthesizing enzymes. Support for intrabulbar, periglomerular dopamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Identification and localization of dopamine receptor subtypes in rat olfactory mucosa and bulb: a combined in situ hybridization and ligand binding radioautographic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

The projections of the A8, A9 and A10 dopaminergic cell bodies: evidence for a nigral-hypothalamic-median eminence dopaminergic pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Organellar proteomics reveals Golgi arginine dimethylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Basic local alignment search tool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009

Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.10.009